Medical Care
Global Nanoparticle-Mediated Delivery Market Research Report 2025
- Mar 11, 25
- ID: 13944
- Pages: 97
- Figures: 98
- Views: 2
The global market for Nanoparticle-Mediated Delivery was valued at US$ 4925 million in the year 2024 and is projected to reach a revised size of US$ 6328 million by 2031, growing at a CAGR of 3.7% during the forecast period.
Nanoparticle drug delivery systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. The modern form of a drug delivery system should minimize side-effects and reduce both dosage and dosage frequency. Recently, nanoparticles have aroused attention due to their potential application for effective drug delivery.
In this report, we only study liposomal/lipid nanoparticle drug delivery system.
LNPs became more widely known in late 2020, as some COVID-19 vaccines that use RNA vaccine technology coat the fragile mRNA strands with PEGylated lipid nanoparticles as their delivery vehicle (including both the Moderna and the Pfizer–BioNTech COVID-19 vaccines).
In this report, the COVID-19 vaccines with lipid nanoparticles technologies are not covered. The COVID-19 vaccines launch on the end of 2020. We expect revenue for COVID-19 vaccines with lipid nanoparticles technologies in 2021 to be approximately 37 billion USD.
Global Nanoparticle Drug Delivery Systems key players include Gilead Sciences, CSPC, Pacira, Alnylam, etc. Global top four manufacturers hold a share about 37%.
Asia-Pacific is the largest market, with a share about 37%, followed by Europe, and North America, both have a share over 56 percent.
In terms of product, Liposomes Drugs is the largest segment, with a share over 92%. And in terms of application, the largest application is Retail Pharmacy, followed by Hospital, etc.
This report aims to provide a comprehensive presentation of the global market for Nanoparticle-Mediated Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanoparticle-Mediated Delivery.
The Nanoparticle-Mediated Delivery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nanoparticle-Mediated Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nanoparticle-Mediated Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
BlueWillow Biologics
NovaSOL
Camurus
Ceramisphere
Celgene, CytImmune
Cristal Therapeutics
EnColl
Lena Nanoceutics Ltd.
EyePoint Pharmaceuticals
Nanobiotix
NanoCarrier
Nanospectra
NanOlogy
Selecta Biosciences
Parvus Therapeutics
Starpharma
Tarveda Therapeutics
Segment by Type
Biological Origin
Non-Biological Origin
Segment by Application
Drug Delivery
Gene Delivery
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nanoparticle-Mediated Delivery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Nanoparticle drug delivery systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. The modern form of a drug delivery system should minimize side-effects and reduce both dosage and dosage frequency. Recently, nanoparticles have aroused attention due to their potential application for effective drug delivery.
In this report, we only study liposomal/lipid nanoparticle drug delivery system.
LNPs became more widely known in late 2020, as some COVID-19 vaccines that use RNA vaccine technology coat the fragile mRNA strands with PEGylated lipid nanoparticles as their delivery vehicle (including both the Moderna and the Pfizer–BioNTech COVID-19 vaccines).
In this report, the COVID-19 vaccines with lipid nanoparticles technologies are not covered. The COVID-19 vaccines launch on the end of 2020. We expect revenue for COVID-19 vaccines with lipid nanoparticles technologies in 2021 to be approximately 37 billion USD.
Global Nanoparticle Drug Delivery Systems key players include Gilead Sciences, CSPC, Pacira, Alnylam, etc. Global top four manufacturers hold a share about 37%.
Asia-Pacific is the largest market, with a share about 37%, followed by Europe, and North America, both have a share over 56 percent.
In terms of product, Liposomes Drugs is the largest segment, with a share over 92%. And in terms of application, the largest application is Retail Pharmacy, followed by Hospital, etc.
This report aims to provide a comprehensive presentation of the global market for Nanoparticle-Mediated Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanoparticle-Mediated Delivery.
The Nanoparticle-Mediated Delivery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nanoparticle-Mediated Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nanoparticle-Mediated Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
BlueWillow Biologics
NovaSOL
Camurus
Ceramisphere
Celgene, CytImmune
Cristal Therapeutics
EnColl
Lena Nanoceutics Ltd.
EyePoint Pharmaceuticals
Nanobiotix
NanoCarrier
Nanospectra
NanOlogy
Selecta Biosciences
Parvus Therapeutics
Starpharma
Tarveda Therapeutics
Segment by Type
Biological Origin
Non-Biological Origin
Segment by Application
Drug Delivery
Gene Delivery
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nanoparticle-Mediated Delivery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nanoparticle-Mediated Delivery Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Biological Origin
1.2.3 Non-Biological Origin
1.3 Market by Application
1.3.1 Global Nanoparticle-Mediated Delivery Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Drug Delivery
1.3.3 Gene Delivery
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nanoparticle-Mediated Delivery Market Perspective (2020-2031)
2.2 Global Nanoparticle-Mediated Delivery Growth Trends by Region
2.2.1 Global Nanoparticle-Mediated Delivery Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Nanoparticle-Mediated Delivery Historic Market Size by Region (2020-2025)
2.2.3 Nanoparticle-Mediated Delivery Forecasted Market Size by Region (2026-2031)
2.3 Nanoparticle-Mediated Delivery Market Dynamics
2.3.1 Nanoparticle-Mediated Delivery Industry Trends
2.3.2 Nanoparticle-Mediated Delivery Market Drivers
2.3.3 Nanoparticle-Mediated Delivery Market Challenges
2.3.4 Nanoparticle-Mediated Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nanoparticle-Mediated Delivery Players by Revenue
3.1.1 Global Top Nanoparticle-Mediated Delivery Players by Revenue (2020-2025)
3.1.2 Global Nanoparticle-Mediated Delivery Revenue Market Share by Players (2020-2025)
3.2 Global Nanoparticle-Mediated Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Nanoparticle-Mediated Delivery Revenue
3.4 Global Nanoparticle-Mediated Delivery Market Concentration Ratio
3.4.1 Global Nanoparticle-Mediated Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanoparticle-Mediated Delivery Revenue in 2024
3.5 Global Key Players of Nanoparticle-Mediated Delivery Head office and Area Served
3.6 Global Key Players of Nanoparticle-Mediated Delivery, Product and Application
3.7 Global Key Players of Nanoparticle-Mediated Delivery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nanoparticle-Mediated Delivery Breakdown Data by Type
4.1 Global Nanoparticle-Mediated Delivery Historic Market Size by Type (2020-2025)
4.2 Global Nanoparticle-Mediated Delivery Forecasted Market Size by Type (2026-2031)
5 Nanoparticle-Mediated Delivery Breakdown Data by Application
5.1 Global Nanoparticle-Mediated Delivery Historic Market Size by Application (2020-2025)
5.2 Global Nanoparticle-Mediated Delivery Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Nanoparticle-Mediated Delivery Market Size (2020-2031)
6.2 North America Nanoparticle-Mediated Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Nanoparticle-Mediated Delivery Market Size by Country (2020-2025)
6.4 North America Nanoparticle-Mediated Delivery Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nanoparticle-Mediated Delivery Market Size (2020-2031)
7.2 Europe Nanoparticle-Mediated Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Nanoparticle-Mediated Delivery Market Size by Country (2020-2025)
7.4 Europe Nanoparticle-Mediated Delivery Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nanoparticle-Mediated Delivery Market Size (2020-2031)
8.2 Asia-Pacific Nanoparticle-Mediated Delivery Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Nanoparticle-Mediated Delivery Market Size by Region (2020-2025)
8.4 Asia-Pacific Nanoparticle-Mediated Delivery Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nanoparticle-Mediated Delivery Market Size (2020-2031)
9.2 Latin America Nanoparticle-Mediated Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Nanoparticle-Mediated Delivery Market Size by Country (2020-2025)
9.4 Latin America Nanoparticle-Mediated Delivery Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nanoparticle-Mediated Delivery Market Size (2020-2031)
10.2 Middle East & Africa Nanoparticle-Mediated Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Nanoparticle-Mediated Delivery Market Size by Country (2020-2025)
10.4 Middle East & Africa Nanoparticle-Mediated Delivery Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Nanoparticle-Mediated Delivery Introduction
11.1.4 AbbVie Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.1.5 AbbVie Recent Development
11.2 BlueWillow Biologics
11.2.1 BlueWillow Biologics Company Details
11.2.2 BlueWillow Biologics Business Overview
11.2.3 BlueWillow Biologics Nanoparticle-Mediated Delivery Introduction
11.2.4 BlueWillow Biologics Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.2.5 BlueWillow Biologics Recent Development
11.3 NovaSOL
11.3.1 NovaSOL Company Details
11.3.2 NovaSOL Business Overview
11.3.3 NovaSOL Nanoparticle-Mediated Delivery Introduction
11.3.4 NovaSOL Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.3.5 NovaSOL Recent Development
11.4 Camurus
11.4.1 Camurus Company Details
11.4.2 Camurus Business Overview
11.4.3 Camurus Nanoparticle-Mediated Delivery Introduction
11.4.4 Camurus Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.4.5 Camurus Recent Development
11.5 Ceramisphere
11.5.1 Ceramisphere Company Details
11.5.2 Ceramisphere Business Overview
11.5.3 Ceramisphere Nanoparticle-Mediated Delivery Introduction
11.5.4 Ceramisphere Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.5.5 Ceramisphere Recent Development
11.6 Celgene, CytImmune
11.6.1 Celgene, CytImmune Company Details
11.6.2 Celgene, CytImmune Business Overview
11.6.3 Celgene, CytImmune Nanoparticle-Mediated Delivery Introduction
11.6.4 Celgene, CytImmune Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.6.5 Celgene, CytImmune Recent Development
11.7 Cristal Therapeutics
11.7.1 Cristal Therapeutics Company Details
11.7.2 Cristal Therapeutics Business Overview
11.7.3 Cristal Therapeutics Nanoparticle-Mediated Delivery Introduction
11.7.4 Cristal Therapeutics Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.7.5 Cristal Therapeutics Recent Development
11.8 EnColl
11.8.1 EnColl Company Details
11.8.2 EnColl Business Overview
11.8.3 EnColl Nanoparticle-Mediated Delivery Introduction
11.8.4 EnColl Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.8.5 EnColl Recent Development
11.9 Lena Nanoceutics Ltd.
11.9.1 Lena Nanoceutics Ltd. Company Details
11.9.2 Lena Nanoceutics Ltd. Business Overview
11.9.3 Lena Nanoceutics Ltd. Nanoparticle-Mediated Delivery Introduction
11.9.4 Lena Nanoceutics Ltd. Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.9.5 Lena Nanoceutics Ltd. Recent Development
11.10 EyePoint Pharmaceuticals
11.10.1 EyePoint Pharmaceuticals Company Details
11.10.2 EyePoint Pharmaceuticals Business Overview
11.10.3 EyePoint Pharmaceuticals Nanoparticle-Mediated Delivery Introduction
11.10.4 EyePoint Pharmaceuticals Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.10.5 EyePoint Pharmaceuticals Recent Development
11.11 Nanobiotix
11.11.1 Nanobiotix Company Details
11.11.2 Nanobiotix Business Overview
11.11.3 Nanobiotix Nanoparticle-Mediated Delivery Introduction
11.11.4 Nanobiotix Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.11.5 Nanobiotix Recent Development
11.12 NanoCarrier
11.12.1 NanoCarrier Company Details
11.12.2 NanoCarrier Business Overview
11.12.3 NanoCarrier Nanoparticle-Mediated Delivery Introduction
11.12.4 NanoCarrier Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.12.5 NanoCarrier Recent Development
11.13 Nanospectra
11.13.1 Nanospectra Company Details
11.13.2 Nanospectra Business Overview
11.13.3 Nanospectra Nanoparticle-Mediated Delivery Introduction
11.13.4 Nanospectra Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.13.5 Nanospectra Recent Development
11.14 NanOlogy
11.14.1 NanOlogy Company Details
11.14.2 NanOlogy Business Overview
11.14.3 NanOlogy Nanoparticle-Mediated Delivery Introduction
11.14.4 NanOlogy Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.14.5 NanOlogy Recent Development
11.15 Selecta Biosciences
11.15.1 Selecta Biosciences Company Details
11.15.2 Selecta Biosciences Business Overview
11.15.3 Selecta Biosciences Nanoparticle-Mediated Delivery Introduction
11.15.4 Selecta Biosciences Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.15.5 Selecta Biosciences Recent Development
11.16 Parvus Therapeutics
11.16.1 Parvus Therapeutics Company Details
11.16.2 Parvus Therapeutics Business Overview
11.16.3 Parvus Therapeutics Nanoparticle-Mediated Delivery Introduction
11.16.4 Parvus Therapeutics Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.16.5 Parvus Therapeutics Recent Development
11.17 Starpharma
11.17.1 Starpharma Company Details
11.17.2 Starpharma Business Overview
11.17.3 Starpharma Nanoparticle-Mediated Delivery Introduction
11.17.4 Starpharma Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.17.5 Starpharma Recent Development
11.18 Tarveda Therapeutics
11.18.1 Tarveda Therapeutics Company Details
11.18.2 Tarveda Therapeutics Business Overview
11.18.3 Tarveda Therapeutics Nanoparticle-Mediated Delivery Introduction
11.18.4 Tarveda Therapeutics Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.18.5 Tarveda Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nanoparticle-Mediated Delivery Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Biological Origin
1.2.3 Non-Biological Origin
1.3 Market by Application
1.3.1 Global Nanoparticle-Mediated Delivery Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Drug Delivery
1.3.3 Gene Delivery
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nanoparticle-Mediated Delivery Market Perspective (2020-2031)
2.2 Global Nanoparticle-Mediated Delivery Growth Trends by Region
2.2.1 Global Nanoparticle-Mediated Delivery Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Nanoparticle-Mediated Delivery Historic Market Size by Region (2020-2025)
2.2.3 Nanoparticle-Mediated Delivery Forecasted Market Size by Region (2026-2031)
2.3 Nanoparticle-Mediated Delivery Market Dynamics
2.3.1 Nanoparticle-Mediated Delivery Industry Trends
2.3.2 Nanoparticle-Mediated Delivery Market Drivers
2.3.3 Nanoparticle-Mediated Delivery Market Challenges
2.3.4 Nanoparticle-Mediated Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nanoparticle-Mediated Delivery Players by Revenue
3.1.1 Global Top Nanoparticle-Mediated Delivery Players by Revenue (2020-2025)
3.1.2 Global Nanoparticle-Mediated Delivery Revenue Market Share by Players (2020-2025)
3.2 Global Nanoparticle-Mediated Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Nanoparticle-Mediated Delivery Revenue
3.4 Global Nanoparticle-Mediated Delivery Market Concentration Ratio
3.4.1 Global Nanoparticle-Mediated Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanoparticle-Mediated Delivery Revenue in 2024
3.5 Global Key Players of Nanoparticle-Mediated Delivery Head office and Area Served
3.6 Global Key Players of Nanoparticle-Mediated Delivery, Product and Application
3.7 Global Key Players of Nanoparticle-Mediated Delivery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nanoparticle-Mediated Delivery Breakdown Data by Type
4.1 Global Nanoparticle-Mediated Delivery Historic Market Size by Type (2020-2025)
4.2 Global Nanoparticle-Mediated Delivery Forecasted Market Size by Type (2026-2031)
5 Nanoparticle-Mediated Delivery Breakdown Data by Application
5.1 Global Nanoparticle-Mediated Delivery Historic Market Size by Application (2020-2025)
5.2 Global Nanoparticle-Mediated Delivery Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Nanoparticle-Mediated Delivery Market Size (2020-2031)
6.2 North America Nanoparticle-Mediated Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Nanoparticle-Mediated Delivery Market Size by Country (2020-2025)
6.4 North America Nanoparticle-Mediated Delivery Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nanoparticle-Mediated Delivery Market Size (2020-2031)
7.2 Europe Nanoparticle-Mediated Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Nanoparticle-Mediated Delivery Market Size by Country (2020-2025)
7.4 Europe Nanoparticle-Mediated Delivery Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nanoparticle-Mediated Delivery Market Size (2020-2031)
8.2 Asia-Pacific Nanoparticle-Mediated Delivery Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Nanoparticle-Mediated Delivery Market Size by Region (2020-2025)
8.4 Asia-Pacific Nanoparticle-Mediated Delivery Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nanoparticle-Mediated Delivery Market Size (2020-2031)
9.2 Latin America Nanoparticle-Mediated Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Nanoparticle-Mediated Delivery Market Size by Country (2020-2025)
9.4 Latin America Nanoparticle-Mediated Delivery Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nanoparticle-Mediated Delivery Market Size (2020-2031)
10.2 Middle East & Africa Nanoparticle-Mediated Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Nanoparticle-Mediated Delivery Market Size by Country (2020-2025)
10.4 Middle East & Africa Nanoparticle-Mediated Delivery Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Nanoparticle-Mediated Delivery Introduction
11.1.4 AbbVie Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.1.5 AbbVie Recent Development
11.2 BlueWillow Biologics
11.2.1 BlueWillow Biologics Company Details
11.2.2 BlueWillow Biologics Business Overview
11.2.3 BlueWillow Biologics Nanoparticle-Mediated Delivery Introduction
11.2.4 BlueWillow Biologics Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.2.5 BlueWillow Biologics Recent Development
11.3 NovaSOL
11.3.1 NovaSOL Company Details
11.3.2 NovaSOL Business Overview
11.3.3 NovaSOL Nanoparticle-Mediated Delivery Introduction
11.3.4 NovaSOL Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.3.5 NovaSOL Recent Development
11.4 Camurus
11.4.1 Camurus Company Details
11.4.2 Camurus Business Overview
11.4.3 Camurus Nanoparticle-Mediated Delivery Introduction
11.4.4 Camurus Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.4.5 Camurus Recent Development
11.5 Ceramisphere
11.5.1 Ceramisphere Company Details
11.5.2 Ceramisphere Business Overview
11.5.3 Ceramisphere Nanoparticle-Mediated Delivery Introduction
11.5.4 Ceramisphere Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.5.5 Ceramisphere Recent Development
11.6 Celgene, CytImmune
11.6.1 Celgene, CytImmune Company Details
11.6.2 Celgene, CytImmune Business Overview
11.6.3 Celgene, CytImmune Nanoparticle-Mediated Delivery Introduction
11.6.4 Celgene, CytImmune Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.6.5 Celgene, CytImmune Recent Development
11.7 Cristal Therapeutics
11.7.1 Cristal Therapeutics Company Details
11.7.2 Cristal Therapeutics Business Overview
11.7.3 Cristal Therapeutics Nanoparticle-Mediated Delivery Introduction
11.7.4 Cristal Therapeutics Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.7.5 Cristal Therapeutics Recent Development
11.8 EnColl
11.8.1 EnColl Company Details
11.8.2 EnColl Business Overview
11.8.3 EnColl Nanoparticle-Mediated Delivery Introduction
11.8.4 EnColl Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.8.5 EnColl Recent Development
11.9 Lena Nanoceutics Ltd.
11.9.1 Lena Nanoceutics Ltd. Company Details
11.9.2 Lena Nanoceutics Ltd. Business Overview
11.9.3 Lena Nanoceutics Ltd. Nanoparticle-Mediated Delivery Introduction
11.9.4 Lena Nanoceutics Ltd. Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.9.5 Lena Nanoceutics Ltd. Recent Development
11.10 EyePoint Pharmaceuticals
11.10.1 EyePoint Pharmaceuticals Company Details
11.10.2 EyePoint Pharmaceuticals Business Overview
11.10.3 EyePoint Pharmaceuticals Nanoparticle-Mediated Delivery Introduction
11.10.4 EyePoint Pharmaceuticals Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.10.5 EyePoint Pharmaceuticals Recent Development
11.11 Nanobiotix
11.11.1 Nanobiotix Company Details
11.11.2 Nanobiotix Business Overview
11.11.3 Nanobiotix Nanoparticle-Mediated Delivery Introduction
11.11.4 Nanobiotix Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.11.5 Nanobiotix Recent Development
11.12 NanoCarrier
11.12.1 NanoCarrier Company Details
11.12.2 NanoCarrier Business Overview
11.12.3 NanoCarrier Nanoparticle-Mediated Delivery Introduction
11.12.4 NanoCarrier Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.12.5 NanoCarrier Recent Development
11.13 Nanospectra
11.13.1 Nanospectra Company Details
11.13.2 Nanospectra Business Overview
11.13.3 Nanospectra Nanoparticle-Mediated Delivery Introduction
11.13.4 Nanospectra Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.13.5 Nanospectra Recent Development
11.14 NanOlogy
11.14.1 NanOlogy Company Details
11.14.2 NanOlogy Business Overview
11.14.3 NanOlogy Nanoparticle-Mediated Delivery Introduction
11.14.4 NanOlogy Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.14.5 NanOlogy Recent Development
11.15 Selecta Biosciences
11.15.1 Selecta Biosciences Company Details
11.15.2 Selecta Biosciences Business Overview
11.15.3 Selecta Biosciences Nanoparticle-Mediated Delivery Introduction
11.15.4 Selecta Biosciences Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.15.5 Selecta Biosciences Recent Development
11.16 Parvus Therapeutics
11.16.1 Parvus Therapeutics Company Details
11.16.2 Parvus Therapeutics Business Overview
11.16.3 Parvus Therapeutics Nanoparticle-Mediated Delivery Introduction
11.16.4 Parvus Therapeutics Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.16.5 Parvus Therapeutics Recent Development
11.17 Starpharma
11.17.1 Starpharma Company Details
11.17.2 Starpharma Business Overview
11.17.3 Starpharma Nanoparticle-Mediated Delivery Introduction
11.17.4 Starpharma Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.17.5 Starpharma Recent Development
11.18 Tarveda Therapeutics
11.18.1 Tarveda Therapeutics Company Details
11.18.2 Tarveda Therapeutics Business Overview
11.18.3 Tarveda Therapeutics Nanoparticle-Mediated Delivery Introduction
11.18.4 Tarveda Therapeutics Revenue in Nanoparticle-Mediated Delivery Business (2020-2025)
11.18.5 Tarveda Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Nanoparticle-Mediated Delivery Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Biological Origin
Table 3. Key Players of Non-Biological Origin
Table 4. Global Nanoparticle-Mediated Delivery Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Nanoparticle-Mediated Delivery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Nanoparticle-Mediated Delivery Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Nanoparticle-Mediated Delivery Market Share by Region (2020-2025)
Table 8. Global Nanoparticle-Mediated Delivery Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Nanoparticle-Mediated Delivery Market Share by Region (2026-2031)
Table 10. Nanoparticle-Mediated Delivery Market Trends
Table 11. Nanoparticle-Mediated Delivery Market Drivers
Table 12. Nanoparticle-Mediated Delivery Market Challenges
Table 13. Nanoparticle-Mediated Delivery Market Restraints
Table 14. Global Nanoparticle-Mediated Delivery Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Nanoparticle-Mediated Delivery Market Share by Players (2020-2025)
Table 16. Global Top Nanoparticle-Mediated Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanoparticle-Mediated Delivery as of 2024)
Table 17. Ranking of Global Top Nanoparticle-Mediated Delivery Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Nanoparticle-Mediated Delivery Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Nanoparticle-Mediated Delivery, Headquarters and Area Served
Table 20. Global Key Players of Nanoparticle-Mediated Delivery, Product and Application
Table 21. Global Key Players of Nanoparticle-Mediated Delivery, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Nanoparticle-Mediated Delivery Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Nanoparticle-Mediated Delivery Revenue Market Share by Type (2020-2025)
Table 25. Global Nanoparticle-Mediated Delivery Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Nanoparticle-Mediated Delivery Revenue Market Share by Type (2026-2031)
Table 27. Global Nanoparticle-Mediated Delivery Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Nanoparticle-Mediated Delivery Revenue Market Share by Application (2020-2025)
Table 29. Global Nanoparticle-Mediated Delivery Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Nanoparticle-Mediated Delivery Revenue Market Share by Application (2026-2031)
Table 31. North America Nanoparticle-Mediated Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Nanoparticle-Mediated Delivery Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Nanoparticle-Mediated Delivery Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Nanoparticle-Mediated Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Nanoparticle-Mediated Delivery Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Nanoparticle-Mediated Delivery Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Nanoparticle-Mediated Delivery Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Nanoparticle-Mediated Delivery Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Nanoparticle-Mediated Delivery Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Nanoparticle-Mediated Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Nanoparticle-Mediated Delivery Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Nanoparticle-Mediated Delivery Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Nanoparticle-Mediated Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Nanoparticle-Mediated Delivery Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Nanoparticle-Mediated Delivery Market Size by Country (2026-2031) & (US$ Million)
Table 46. AbbVie Company Details
Table 47. AbbVie Business Overview
Table 48. AbbVie Nanoparticle-Mediated Delivery Product
Table 49. AbbVie Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 50. AbbVie Recent Development
Table 51. BlueWillow Biologics Company Details
Table 52. BlueWillow Biologics Business Overview
Table 53. BlueWillow Biologics Nanoparticle-Mediated Delivery Product
Table 54. BlueWillow Biologics Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 55. BlueWillow Biologics Recent Development
Table 56. NovaSOL Company Details
Table 57. NovaSOL Business Overview
Table 58. NovaSOL Nanoparticle-Mediated Delivery Product
Table 59. NovaSOL Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 60. NovaSOL Recent Development
Table 61. Camurus Company Details
Table 62. Camurus Business Overview
Table 63. Camurus Nanoparticle-Mediated Delivery Product
Table 64. Camurus Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 65. Camurus Recent Development
Table 66. Ceramisphere Company Details
Table 67. Ceramisphere Business Overview
Table 68. Ceramisphere Nanoparticle-Mediated Delivery Product
Table 69. Ceramisphere Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 70. Ceramisphere Recent Development
Table 71. Celgene, CytImmune Company Details
Table 72. Celgene, CytImmune Business Overview
Table 73. Celgene, CytImmune Nanoparticle-Mediated Delivery Product
Table 74. Celgene, CytImmune Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 75. Celgene, CytImmune Recent Development
Table 76. Cristal Therapeutics Company Details
Table 77. Cristal Therapeutics Business Overview
Table 78. Cristal Therapeutics Nanoparticle-Mediated Delivery Product
Table 79. Cristal Therapeutics Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 80. Cristal Therapeutics Recent Development
Table 81. EnColl Company Details
Table 82. EnColl Business Overview
Table 83. EnColl Nanoparticle-Mediated Delivery Product
Table 84. EnColl Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 85. EnColl Recent Development
Table 86. Lena Nanoceutics Ltd. Company Details
Table 87. Lena Nanoceutics Ltd. Business Overview
Table 88. Lena Nanoceutics Ltd. Nanoparticle-Mediated Delivery Product
Table 89. Lena Nanoceutics Ltd. Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 90. Lena Nanoceutics Ltd. Recent Development
Table 91. EyePoint Pharmaceuticals Company Details
Table 92. EyePoint Pharmaceuticals Business Overview
Table 93. EyePoint Pharmaceuticals Nanoparticle-Mediated Delivery Product
Table 94. EyePoint Pharmaceuticals Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 95. EyePoint Pharmaceuticals Recent Development
Table 96. Nanobiotix Company Details
Table 97. Nanobiotix Business Overview
Table 98. Nanobiotix Nanoparticle-Mediated Delivery Product
Table 99. Nanobiotix Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 100. Nanobiotix Recent Development
Table 101. NanoCarrier Company Details
Table 102. NanoCarrier Business Overview
Table 103. NanoCarrier Nanoparticle-Mediated Delivery Product
Table 104. NanoCarrier Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 105. NanoCarrier Recent Development
Table 106. Nanospectra Company Details
Table 107. Nanospectra Business Overview
Table 108. Nanospectra Nanoparticle-Mediated Delivery Product
Table 109. Nanospectra Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 110. Nanospectra Recent Development
Table 111. NanOlogy Company Details
Table 112. NanOlogy Business Overview
Table 113. NanOlogy Nanoparticle-Mediated Delivery Product
Table 114. NanOlogy Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 115. NanOlogy Recent Development
Table 116. Selecta Biosciences Company Details
Table 117. Selecta Biosciences Business Overview
Table 118. Selecta Biosciences Nanoparticle-Mediated Delivery Product
Table 119. Selecta Biosciences Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 120. Selecta Biosciences Recent Development
Table 121. Parvus Therapeutics Company Details
Table 122. Parvus Therapeutics Business Overview
Table 123. Parvus Therapeutics Nanoparticle-Mediated Delivery Product
Table 124. Parvus Therapeutics Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 125. Parvus Therapeutics Recent Development
Table 126. Starpharma Company Details
Table 127. Starpharma Business Overview
Table 128. Starpharma Nanoparticle-Mediated Delivery Product
Table 129. Starpharma Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 130. Starpharma Recent Development
Table 131. Tarveda Therapeutics Company Details
Table 132. Tarveda Therapeutics Business Overview
Table 133. Tarveda Therapeutics Nanoparticle-Mediated Delivery Product
Table 134. Tarveda Therapeutics Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 135. Tarveda Therapeutics Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
Table 139. Authors List of This Report
List of Figures
Figure 1. Nanoparticle-Mediated Delivery Picture
Figure 2. Global Nanoparticle-Mediated Delivery Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nanoparticle-Mediated Delivery Market Share by Type: 2024 VS 2031
Figure 4. Biological Origin Features
Figure 5. Non-Biological Origin Features
Figure 6. Global Nanoparticle-Mediated Delivery Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Nanoparticle-Mediated Delivery Market Share by Application: 2024 VS 2031
Figure 8. Drug Delivery Case Studies
Figure 9. Gene Delivery Case Studies
Figure 10. Nanoparticle-Mediated Delivery Report Years Considered
Figure 11. Global Nanoparticle-Mediated Delivery Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Nanoparticle-Mediated Delivery Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Nanoparticle-Mediated Delivery Market Share by Region: 2024 VS 2031
Figure 14. Global Nanoparticle-Mediated Delivery Market Share by Players in 2024
Figure 15. Global Top Nanoparticle-Mediated Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanoparticle-Mediated Delivery as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Nanoparticle-Mediated Delivery Revenue in 2024
Figure 17. North America Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Nanoparticle-Mediated Delivery Market Share by Country (2020-2031)
Figure 19. United States Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Nanoparticle-Mediated Delivery Market Share by Country (2020-2031)
Figure 23. Germany Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Nanoparticle-Mediated Delivery Market Share by Region (2020-2031)
Figure 31. China Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Nanoparticle-Mediated Delivery Market Share by Country (2020-2031)
Figure 39. Mexico Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Nanoparticle-Mediated Delivery Market Share by Country (2020-2031)
Figure 43. Turkey Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. AbbVie Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 47. BlueWillow Biologics Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 48. NovaSOL Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 49. Camurus Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 50. Ceramisphere Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 51. Celgene, CytImmune Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 52. Cristal Therapeutics Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 53. EnColl Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 54. Lena Nanoceutics Ltd. Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 55. EyePoint Pharmaceuticals Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 56. Nanobiotix Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 57. NanoCarrier Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 58. Nanospectra Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 59. NanOlogy Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 60. Selecta Biosciences Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 61. Parvus Therapeutics Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 62. Starpharma Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 63. Tarveda Therapeutics Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Nanoparticle-Mediated Delivery Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Biological Origin
Table 3. Key Players of Non-Biological Origin
Table 4. Global Nanoparticle-Mediated Delivery Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Nanoparticle-Mediated Delivery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Nanoparticle-Mediated Delivery Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Nanoparticle-Mediated Delivery Market Share by Region (2020-2025)
Table 8. Global Nanoparticle-Mediated Delivery Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Nanoparticle-Mediated Delivery Market Share by Region (2026-2031)
Table 10. Nanoparticle-Mediated Delivery Market Trends
Table 11. Nanoparticle-Mediated Delivery Market Drivers
Table 12. Nanoparticle-Mediated Delivery Market Challenges
Table 13. Nanoparticle-Mediated Delivery Market Restraints
Table 14. Global Nanoparticle-Mediated Delivery Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Nanoparticle-Mediated Delivery Market Share by Players (2020-2025)
Table 16. Global Top Nanoparticle-Mediated Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanoparticle-Mediated Delivery as of 2024)
Table 17. Ranking of Global Top Nanoparticle-Mediated Delivery Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Nanoparticle-Mediated Delivery Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Nanoparticle-Mediated Delivery, Headquarters and Area Served
Table 20. Global Key Players of Nanoparticle-Mediated Delivery, Product and Application
Table 21. Global Key Players of Nanoparticle-Mediated Delivery, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Nanoparticle-Mediated Delivery Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Nanoparticle-Mediated Delivery Revenue Market Share by Type (2020-2025)
Table 25. Global Nanoparticle-Mediated Delivery Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Nanoparticle-Mediated Delivery Revenue Market Share by Type (2026-2031)
Table 27. Global Nanoparticle-Mediated Delivery Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Nanoparticle-Mediated Delivery Revenue Market Share by Application (2020-2025)
Table 29. Global Nanoparticle-Mediated Delivery Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Nanoparticle-Mediated Delivery Revenue Market Share by Application (2026-2031)
Table 31. North America Nanoparticle-Mediated Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Nanoparticle-Mediated Delivery Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Nanoparticle-Mediated Delivery Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Nanoparticle-Mediated Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Nanoparticle-Mediated Delivery Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Nanoparticle-Mediated Delivery Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Nanoparticle-Mediated Delivery Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Nanoparticle-Mediated Delivery Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Nanoparticle-Mediated Delivery Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Nanoparticle-Mediated Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Nanoparticle-Mediated Delivery Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Nanoparticle-Mediated Delivery Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Nanoparticle-Mediated Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Nanoparticle-Mediated Delivery Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Nanoparticle-Mediated Delivery Market Size by Country (2026-2031) & (US$ Million)
Table 46. AbbVie Company Details
Table 47. AbbVie Business Overview
Table 48. AbbVie Nanoparticle-Mediated Delivery Product
Table 49. AbbVie Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 50. AbbVie Recent Development
Table 51. BlueWillow Biologics Company Details
Table 52. BlueWillow Biologics Business Overview
Table 53. BlueWillow Biologics Nanoparticle-Mediated Delivery Product
Table 54. BlueWillow Biologics Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 55. BlueWillow Biologics Recent Development
Table 56. NovaSOL Company Details
Table 57. NovaSOL Business Overview
Table 58. NovaSOL Nanoparticle-Mediated Delivery Product
Table 59. NovaSOL Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 60. NovaSOL Recent Development
Table 61. Camurus Company Details
Table 62. Camurus Business Overview
Table 63. Camurus Nanoparticle-Mediated Delivery Product
Table 64. Camurus Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 65. Camurus Recent Development
Table 66. Ceramisphere Company Details
Table 67. Ceramisphere Business Overview
Table 68. Ceramisphere Nanoparticle-Mediated Delivery Product
Table 69. Ceramisphere Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 70. Ceramisphere Recent Development
Table 71. Celgene, CytImmune Company Details
Table 72. Celgene, CytImmune Business Overview
Table 73. Celgene, CytImmune Nanoparticle-Mediated Delivery Product
Table 74. Celgene, CytImmune Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 75. Celgene, CytImmune Recent Development
Table 76. Cristal Therapeutics Company Details
Table 77. Cristal Therapeutics Business Overview
Table 78. Cristal Therapeutics Nanoparticle-Mediated Delivery Product
Table 79. Cristal Therapeutics Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 80. Cristal Therapeutics Recent Development
Table 81. EnColl Company Details
Table 82. EnColl Business Overview
Table 83. EnColl Nanoparticle-Mediated Delivery Product
Table 84. EnColl Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 85. EnColl Recent Development
Table 86. Lena Nanoceutics Ltd. Company Details
Table 87. Lena Nanoceutics Ltd. Business Overview
Table 88. Lena Nanoceutics Ltd. Nanoparticle-Mediated Delivery Product
Table 89. Lena Nanoceutics Ltd. Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 90. Lena Nanoceutics Ltd. Recent Development
Table 91. EyePoint Pharmaceuticals Company Details
Table 92. EyePoint Pharmaceuticals Business Overview
Table 93. EyePoint Pharmaceuticals Nanoparticle-Mediated Delivery Product
Table 94. EyePoint Pharmaceuticals Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 95. EyePoint Pharmaceuticals Recent Development
Table 96. Nanobiotix Company Details
Table 97. Nanobiotix Business Overview
Table 98. Nanobiotix Nanoparticle-Mediated Delivery Product
Table 99. Nanobiotix Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 100. Nanobiotix Recent Development
Table 101. NanoCarrier Company Details
Table 102. NanoCarrier Business Overview
Table 103. NanoCarrier Nanoparticle-Mediated Delivery Product
Table 104. NanoCarrier Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 105. NanoCarrier Recent Development
Table 106. Nanospectra Company Details
Table 107. Nanospectra Business Overview
Table 108. Nanospectra Nanoparticle-Mediated Delivery Product
Table 109. Nanospectra Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 110. Nanospectra Recent Development
Table 111. NanOlogy Company Details
Table 112. NanOlogy Business Overview
Table 113. NanOlogy Nanoparticle-Mediated Delivery Product
Table 114. NanOlogy Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 115. NanOlogy Recent Development
Table 116. Selecta Biosciences Company Details
Table 117. Selecta Biosciences Business Overview
Table 118. Selecta Biosciences Nanoparticle-Mediated Delivery Product
Table 119. Selecta Biosciences Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 120. Selecta Biosciences Recent Development
Table 121. Parvus Therapeutics Company Details
Table 122. Parvus Therapeutics Business Overview
Table 123. Parvus Therapeutics Nanoparticle-Mediated Delivery Product
Table 124. Parvus Therapeutics Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 125. Parvus Therapeutics Recent Development
Table 126. Starpharma Company Details
Table 127. Starpharma Business Overview
Table 128. Starpharma Nanoparticle-Mediated Delivery Product
Table 129. Starpharma Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 130. Starpharma Recent Development
Table 131. Tarveda Therapeutics Company Details
Table 132. Tarveda Therapeutics Business Overview
Table 133. Tarveda Therapeutics Nanoparticle-Mediated Delivery Product
Table 134. Tarveda Therapeutics Revenue in Nanoparticle-Mediated Delivery Business (2020-2025) & (US$ Million)
Table 135. Tarveda Therapeutics Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
Table 139. Authors List of This Report
List of Figures
Figure 1. Nanoparticle-Mediated Delivery Picture
Figure 2. Global Nanoparticle-Mediated Delivery Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nanoparticle-Mediated Delivery Market Share by Type: 2024 VS 2031
Figure 4. Biological Origin Features
Figure 5. Non-Biological Origin Features
Figure 6. Global Nanoparticle-Mediated Delivery Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Nanoparticle-Mediated Delivery Market Share by Application: 2024 VS 2031
Figure 8. Drug Delivery Case Studies
Figure 9. Gene Delivery Case Studies
Figure 10. Nanoparticle-Mediated Delivery Report Years Considered
Figure 11. Global Nanoparticle-Mediated Delivery Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Nanoparticle-Mediated Delivery Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Nanoparticle-Mediated Delivery Market Share by Region: 2024 VS 2031
Figure 14. Global Nanoparticle-Mediated Delivery Market Share by Players in 2024
Figure 15. Global Top Nanoparticle-Mediated Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanoparticle-Mediated Delivery as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Nanoparticle-Mediated Delivery Revenue in 2024
Figure 17. North America Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Nanoparticle-Mediated Delivery Market Share by Country (2020-2031)
Figure 19. United States Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Nanoparticle-Mediated Delivery Market Share by Country (2020-2031)
Figure 23. Germany Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Nanoparticle-Mediated Delivery Market Share by Region (2020-2031)
Figure 31. China Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Nanoparticle-Mediated Delivery Market Share by Country (2020-2031)
Figure 39. Mexico Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Nanoparticle-Mediated Delivery Market Share by Country (2020-2031)
Figure 43. Turkey Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Nanoparticle-Mediated Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. AbbVie Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 47. BlueWillow Biologics Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 48. NovaSOL Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 49. Camurus Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 50. Ceramisphere Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 51. Celgene, CytImmune Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 52. Cristal Therapeutics Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 53. EnColl Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 54. Lena Nanoceutics Ltd. Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 55. EyePoint Pharmaceuticals Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 56. Nanobiotix Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 57. NanoCarrier Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 58. Nanospectra Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 59. NanOlogy Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 60. Selecta Biosciences Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 61. Parvus Therapeutics Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 62. Starpharma Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 63. Tarveda Therapeutics Revenue Growth Rate in Nanoparticle-Mediated Delivery Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Multi-Channel Temperature Controllers Market Research Report 2025
Mar 14, 25
Global Waterproof Action Cameras Market Research Report 2025
Mar 14, 25
Global Infrared IP Cameras Market Research Report 2025
Mar 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232